Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase NA 2Phase 4 1

Status

Completed 5Terminated 1

Sponsor Class

OTHER 4INDUSTRY 2

Study Type

Interventional 6

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Polycystic Ovary Syndrome 5Ovarian Hyperstimulation Syndrome 1Breast Neoplasms 1Anovulation 1

Interventions

Cyclophosphamide 908Carboplatin 785Paclitaxel 739pembrolizumab 738Cisplatin 707Bevacizumab 705Gemcitabine 619Docetaxel 578Rituximab 548Radiotherapy 539Dexamethasone 510Nivolumab 485Doxorubicin 444Fluorouracil 392Capecitabine 376Etoposide 357Pemetrexed 334Cytarabine 334Oxaliplatin 333Lenalidomide 327Prednisone 326fludarabine phosphate 315Erlotinib Hydrochloride 314Trastuzumab 300Leucovorin 299fludarabine 296Vincristine 287Filgrastim 284Bortezomib 284Cetuximab 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Interventional × Has results × Chorionic Gonadotropin × Clear all
NCT00700778 2021-01-25

Recombinant Human Chorionic Gonadotropin in Preventing Breast Cancer in Premenopausal Women With BRCA1 Mutations

Fox Chase Cancer Center

Phase NA Terminated
2 enrolled 3 charts
Breast

Breast Neoplasms

NCT00747617 2018-11-21

Theca Cell Function in Women With Polycystic Ovary Syndrome (PCOS)

University of California, San Diego

Phase 3 Completed
25 enrolled 7 charts

Polycystic Ovary Syndrome

NCT01815138 2018-10-26

Co-administration of Low Dose hCG at the Time of GnRH Agonist Trigger or 35 Hours Later for the Prevention of OHSS

UConn Health

Phase 4 Completed
89 enrolled 13 charts
Gynecologic

Polycystic Ovary Syndrome, Ovarian Hyperstimulation Syndrome

NCT00989781 2018-06-04

Mechanisms of Increased Androgen Production Among Women With Polycystic Ovary Syndrome

University of California, San Diego

Phase NA Completed
41 enrolled 8 charts

Polycystic Ovary Syndrome

NCT01653743 2016-01-07

Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women

Merck KGaA, Darmstadt, Germany

Phase 3 Completed
81 enrolled 11 charts

Anovulation, Polycystic Ovary Syndrome

NCT01185704 2014-02-13

ATTAC-PCO

Merck KGaA, Darmstadt, Germany

Phase 3 Completed
136 enrolled 21 charts

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡